This NEJM Quick Take video summarises the results of the PARTNER 2 trial, comparing transcatheter and surgical aortic-valve replacement in intermediate risk patients.
About The Author
Structural Heart Disease Australia is an incorporated association focused on education in valvular and structural cardiac diseases. It was started by group of echocardiographers, anaesthetists, clinical and interventional cardiologists, and cardiothoracic surgeons to provide a useful learning resource for medical professionals.
January 15, 2015
January 18, 2015